Company intelligence / Profile preview

MediOrbis

Cleveland, Ohio, United States

Ownership: Private
Development stage: Other

Overview

MediOrbis delivers AI-driven telemedicine services, achieving significant clinical improvements in chronic disease management (e.g., for diabetes: 60% improved clinical parameters, HbA1c reduction up to 1.3%), high patient satisfaction, and cost-containment in specialty and chronic care settings

Therapeutic areas: CardiovascularOtherEndocrinologyPsychiatry
Modalities: Digital health platformRemote patient monitoringExpert medical opinionVirtual primary and specialty careChronic disease managementWeight loss and lifestyle interventions
Industry: Non-Academic Healthcare

Partnerships

Healthyr (chronic disease management and engagement platform)DarioHealth (remote patient monitoring for diabetes patients)Give an Hour® (mental healthcare access—platform technology donation)

Beyond the preview

Go deeper on MediOrbis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediOrbis.

Explore the full profile